VEGFA and neoplasm: The potential relevance of CRH-system alterations in tumor biology has been suggested by a number of reports showing that urocortins as CRH ligands may inhibit tumor growth via effects on vascularization, promote the apoptosis of endothelial cells, and downregulate VEGF expression in vivo [21, 22].